
DEP to assume oversight of Waverly Twp. superfund site
Although the Precision National Plating site at 198 Ackerly Road ceased storing carcinogenic chromium-containing wastewater in a lagoon in 1970 and the plant was demolished in 2000, its impacts are still apparent as the state Department of Environmental Protection looks to assume oversight of the superfund site from the U.S. Environmental Protection Agency. The DEP is accepting comments until Feb. 19 on a proposed consent order and agreement with the White Plains, New York-based Precision National Plating Services Inc. The order will require Precision to continue performing EPA-mandated monitoring and water treatment, in addition to building a new public waterline.
Precision contaminated the site with total chromium, which includes trivalent and hexavalent chromium, according to the DEP's consent order. Concerns have largely focused on the presence of hexavalent chromium as the major contaminant. Exposure can cause occupational asthma, eye irritation and damage, perforated eardrums, respiratory irritation, kidney damage, liver damage, pulmonary congestion and edema, upper abdominal pain, nose irritation and damage, respiratory cancer, skin irritation, and erosion and discoloration of the teeth, according to the U.S. Occupational Safety and Health Administration, or OSHA.
'The past and present conditions at the Site constitute a release and/or threatened release of hazardous substances and/or contaminants,' the DEP wrote in its consent order, which cites Precision for violating multiple sections of the state's Clean Streams Law, Solid Waste Management Act and Administrative Code for wrongfully discharging industrial waste into Pennsylvania's waters and wrongfully disposing of hazardous waste.
*
The site of the former Precision National Plating factory is seen through a fence surrounding the perimeter in Waverly Thursday, Jan. 23, 2025. (SEAN MCKEAG / STAFF PHOTOGRAPHER)
*
The site of the former Precision National Plating factory is seen through a locked gate off of Ackerly Road in Waverly Thursday, Jan. 23, 2025. (SEAN MCKEAG / STAFF PHOTOGRAPHER)
*
A locked gate restricts access to the former Precision National Plating plant in Waverly Thursday, Jan. 23, 2025. (SEAN MCKEAG / STAFF PHOTOGRAPHER)
Show Caption
1 of 3
The site of the former Precision National Plating factory is seen through a fence surrounding the perimeter in Waverly Thursday, Jan. 23, 2025. (SEAN MCKEAG / STAFF PHOTOGRAPHER)
Expand
In a phone interview Wednesday, retired DEP licensed professional geologist John Mellow recalled working on the site from the 1990s until his retirement in early 2010.
'It was a very controversial site for sure,' he said.
An Archbald resident and member of the Sierra Club's Northeastern Pennsylvania Group chapter, Mellow worked in the DEP's Hazardous Sites Cleanup Program. His role at the time was to make sure the DEP understood the extent of the contamination in all significant aquifers, whether it was a shallow aquifer going to the surface or the aquifers supplying residential wells.
'It was a very serious problem,' Mellow said. 'Hexavalent chromium, it's a human health contaminant that's very toxic.'
The goal now is to get rid of the toxic hexavalent chromium and, over time, the total chromium will also decrease, he said, calling it a long-term process. One part of the remediation is converting hexavalent chromium into trivalent chromium, which Mellow explained is less mobile and less toxic.
'This is a good reason why you have to have environmental regulations,' Mellow said. 'A lot of this was done before there was any requirements to have any kind of monitoring or treatment.'
A history of pollution
Less than a quarter mile from Ackerly Creek, and even closer to residential homes along Arch Avenue in neighboring Glenburn Twp., the Precision site was operational from 1958 until 1999, according to an EPA case summary. Ernest V. Berry Inc. operated the plant until 1971 when Precision National Corporation purchased the property, later changing its name to Precision National Plating Services Inc. in 1987, according to the EPA.
The site initially functioned as a chromium electroplating facility for locomotive crankshafts, and when Precision bought the property, it added an industrial component reconditioning facility, according to an August 2020 work plan from Precision. The reconditioning involved applying a protective and wear-reducing coating that contained chromium to various engine components for the railroad, marine and power industries, according to a September 2006 response approval summary from the EPA.
Chromium contamination in the soil and groundwater occurred between 1958 and 1987, according to Precision's 2020 work plan. From 1958 until around 1970, chromium wastes were disposed of in a lagoon at the northern end of the facility, but in May 1970, the contaminated liquid leaked from a break in the lagoon's retaining wall and was absorbed into the soil in a drainage pathway, with additional hazardous waste-containing substances flowing to the nearby creek, according to the EPA's case summary. Until July 1970, the plant also allowed chromium-containing water to flow into floor drains that discharged to the ground outside, according to a 2012 report from Precision.
The DEP began investigating the site in the 1970s over its waste-handling and disposal procedures, taking action against Precision to reduce groundwater contamination, according to an April 1998 responsiveness summary from the EPA. In response, Precision drained and backfilled its lagoon, provided nearby residents with bottled water beginning in 1979 and moved chromium-contaminated soil from the lagoon and other areas into a vault.
In 1987, Precision released an additional 200 gallons of wastewater from a faulty valve at the plant. A reporter with The Sunday Times described the Feb. 8, 1987, spill, writing that the state was investigating a greenish-yellow liquid that flowed from Precision and down Ackerly Road into Ackerly Creek.
In 1993, Precision began working with the EPA under its Superfund Accelerated Cleanup Model program.
Throughout the 1990s, Precision would go on to drill two wells on Arch Avenue to provide drinking water for residents, install a public waterline for people with contaminated wells, engage in residential well monitoring and soil sampling, long-term groundwater monitoring and the collection and treatment of contaminated groundwater seeping to the surface.
The plant permanently closed in April 1999, and its equipment was decontaminated and either sold or disposed of off-site, according to Precision's 2020 work plan.
With oversight from the EPA and approval from Abington Twp. — now Waverly Twp. — Precision tore down its 45,000-square-foot building in fall 2000, though the remediation efforts were far from over.
The cleanup
Throughout the 2000s, Precision worked to treat and monitor its chromium contamination, largely reducing the levels of hexavalent chromium. With two water treatment systems on-site, water sampling results from April 1, 2023, through June 30, 2023, which were submitted to the EPA on July 12 and are the most recent available online, show trace amounts of hexavalent chromium still present in some samples, though after treatment, the carcinogen is undetectable.
In its latest pollution report from Aug. 6, the EPA summarized the past 20 years of efforts to clean up the site. In September 2005, the EPA approved a plan submitted on behalf of Precision to use calcium polysulfide to reduce the amount of hexavalent chromium in groundwater and soil by turning it into a less toxic form called trivalent chromium, which will remain in the soil and bedrock. Precision began injecting the chemical the following July.
Additional testing in October 2007 and March 2008 confirmed the residual contamination remained at the site, about 18 to 30 feet below ground, according to the EPA.
In August 2008, Precision carried out additional injections to treat those contaminated areas in the shallow bedrock, and hexavalent chromium levels dropped in Ackerly Creek due to a combination of the activities, the EPA reported.
Precision and EPA signed a new administrative settlement agreement and order on consent on May 3, 2012, with multiple rounds of calcium polysulfide injections between fall 2012 and fall 2018.
Semi-annual and quarterly sampling between 2016 and 2020 to document chromium levels showed the injections appeared to have been effective, though some hexavalent chromium persisted in isolated areas, as well as further downhill toward Ackerly Creek, according to the EPA. Precision then targeted those areas in the summer and fall of 2020 with more injections.
The EPA allowed Precision to reduce its chromium surface water sampling from quarterly to semi-annually in 2021 because it continued to keep chromium levels below the minimum requirement in Ackerly Creek. Most samples do not detect hexavalent chromium, and those that do have remained under the minimum levels since July 2016.
The future
With its proposed consent order and agreement, the DEP will require Precision to continue the incomplete corrective actions outlined in the EPA's 2012 settlement. Those are:
* For as long as releases continue, to collect contaminated water from groundwater seeps until total chromium levels remain below 100 parts per billion to prevent human exposure to contaminated groundwater.
* Treat the water from the currently collected seeps.
* Sample semi-annually both on- and off-site groundwater wells and nearby residential wells, with an accelerated schedule during any chemical injections.
* Perform air monitoring during any treatment conducted.
* Groundwater within the contaminate area shall not be used for drinking water until the maximum contaminant level for chromium is reached.
Additionally, Precision will be required to work with Pennsylvania American Water Company to install a waterline extension at and around the site to provide owners of nearby vacant properties within the chromium-impacted area with public water. Pennsylvania American Water does not have any project details at this time, company spokeswoman Susan Turcmanovich said in an email Thursday.
Precision will also have 90 days from the agreement's effective date to provide the DEP with documents showing its efforts to procure environmental covenants for properties impacted by or threatened to be impacted by chromium contamination.
Precision must also submit quarterly progress reports to the DEP.
Attempts to reach attorney Kevin C. Quinn of Kingston-based Hourigan, Kluger and Quinn, who is representing Precision according to the consent order, were unsuccessful.
Jim Davis, the chairman of Glenburn Twp.'s board of supervisors, said his township has been very pleased with the information shared by the EPA throughout the process.
'Obviously a superfund cleanup site and a municipality being able to just make information available to their residents, it's been helpful,' Davis said. 'If the DEP is going to be taking over oversight of this, I'm very comfortable with what direction it's going in.'
Davis has lived in Glenburn Twp. since 2014 and is in his sixth year as a township supervisor, but he grew up half a mile from the Precision site on Oakford Road.
'I know there were a lot of residents that were very much involved, especially the ones that were impacted, who were very upset with what happened, especially with the owner, Precision,' he said, noting the ongoing efforts to cleanup and manage the site. 'The EPA and the DEP have continued to serve the public interests of public health, and I hope that continues.'
A longtime advocate of the Lackawanna River, Bernie McGurl, who is the retired executive director of the Lackawanna River Conservation Association, doubts the chromium will ever be fully removed from the ground. McGurl reviewed the most recent water sampling results submitted by Precision to the EPA.
'It's probably typical of a lot of bad industrial operations that just went on and on and on in the old days before people were cognizant of the potential impacts,' said McGurl, who is now a senior consultant with the LRCA. 'The damage is pretty extensive and deep, and it's going to be persistent in the groundwater — I don't think they can ever rectify it.'
While water samples could be below the minimum level of contamination the day they're tested, they could also spike on other days because there is not a constant testing procedure, he said.
As a result, McGurl lauded the DEP's proposal for Precision to work with Pennsylvania American Water to bring an additional public water supply to the area.
Because the chromium went untreated and unabated for so long, the geology itself is containing the material in minute quantities 'in the nooks and crannies and crevices' of the ledge stone, rocks and groundwater tables, where it would flow into Ackerly Creek and then into the now-depleted Glenburn Pond, McGurl said.
'It's always going to be there,' he said.
To comment on the proposed consent order and agreement, submit written comments to Scott J. Bene in the DEP's Environmental Cleanup and Brownfields Program by emailing sbene@pa.gov, or at 2 Public Square, Wilkes-Barre, PA 18701.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Nerve Soothe Launches All-New Nerve Support Formula in 2025 Amid Surging Interest in Natural Relief Solutions
Public curiosity around nerve health is rising in 2025, with searches, podcasts, and social platforms highlighting natural approaches. Nerve Soothe enters this conversation with a formula designed around ingredient transparency, plant-based extracts, and consumer-driven expectations for wellness support. New York, Aug. 15, 2025 (GLOBE NEWSWIRE) -- This article is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making changes to your diet or supplement routine. Product availability, pricing, and customer experiences may vary. Always verify details with the official brand before making a purchase decision. If you purchase through links in this article, the publisher may earn a commission at no additional cost to you. Nerve Sooth Launches All-New Nerve Support Formula in 2025 Amid Surging Interest in Natural Relief Solutions Public interest in nerve health has surged across search engines, TikTok conversations, and wellness forums in 2025. Nerve Sooth, a new dietary supplement designed with five bio-available fruit, flower, and bark extracts, positions itself at the center of this trend. Market demand for non-clinical approaches to nerve comfort, energy, and resilience continues to grow, and NerveSooth reflects this curiosity with a formula framed around ingredient transparency, consumer-driven design, and a strong emphasis on evolving wellness expectations. The surge in keyword searches for terms like 'natural nerve support,' 'relief from nerve discomfort,' and 'bio-available herbal extracts' reflects how consumers are seeking non-clinical alternatives for everyday wellness in 2025. Nerve Sooth enters this space at a time when public curiosity is at its peak, combining ingredient narratives long discussed in research and traditional wellness circles with a transparency-first design. Explore the Full Nerve Sooth Formula Why Interest in 'Nerve Support' Is Surging in 2025 Across the internet in 2025, conversations about 'nerve support' are showing up everywhere. Google searches for nerve health and related terms have climbed steadily this year, while TikTok creators post short clips about daily routines, sleep hacks, and supplement discussions that attract millions of views. On Reddit, community members swap questions and experiences, often asking about natural approaches they can add to their lifestyle. This shift reflects more than curiosity. Many people feel traditional options do not always give them the comfort or consistency they want, so they are looking for everyday choices they can control. Instead of relying only on clinical solutions, more consumers are turning toward natural wellness and asking what ingredients, practices, or habits might fit into their routine. That demand is creating space for products designed around transparency. Shoppers in 2025 are no longer satisfied with vague promises. They want to see exactly what goes into a formula, where it comes from, and why those ingredients are being used. This is why nerve support has become more than a niche concern. It has joined larger wellness conversations that also touch on stress, energy, balance, and sleep. Nerve Sooth enters this moment as a new option framed around those expectations. Its ingredient-first formula highlights fruit, flower, and bark extracts that people are already discussing online and in wellness communities. By presenting itself with clear labeling and simple choices, NerveSooth fits directly into a marketplace where people are comparing, questioning, and making decisions based on openness. Part of the momentum comes from the influence of creators and podcasts. YouTube hosts now post ingredient breakdowns, while long-form shows feature guest experts talking about nerve wellness trends. What once lived in quiet corners of forums has now spread into mainstream conversations that shape how people think about their health. For many, 2025 marks the first time nerve support feels like a shared topic, not a private struggle. People are talking more openly, seeking practical information, and searching for products that meet their standards. Nerve Sooth is part of that conversation, positioned in a way that reflects what consumers say they want today. Nerve Sooth's Ingredient-First Response to These Trends One of the clearest signals in 2025 is the demand for transparency. Consumers now expect supplement companies to explain exactly what is in their products, how those ingredients are chosen, and why the formula exists in the first place. Nerve Sooth responds to this demand with an ingredient-first approach that highlights clarity, simplicity, and design choices rooted in consumer expectations. Instead of leaning on vague promises or sweeping claims, Nerve Sooth puts its formulation at the center of the conversation. Each bottle includes fruit, flower, and bark extracts that have been historically associated with wellness traditions and studied in modern research. These natural inclusions are combined with essential vitamins and minerals, reflecting the broader curiosity people have about everyday nutrients and their role in maintaining balance. The formula also speaks to what consumers say they want less of. In survey responses and public discussions, phrases like 'clean label,' 'non-GMO,' and 'gluten-free' are repeated often. NerveSooth aligns with those expectations by avoiding unnecessary fillers and highlighting its manufacturing standards. The product is described as all natural, gluten-free, non-GMO, and produced in a facility following GMP guidelines. These are the types of standards consumers now actively look for before making a purchase decision. This ingredient-first strategy places Nerve Sooth in the growing category of supplements that present themselves more like open books than closed bottles. Shoppers in 2025 want to feel confident they are making informed choices. By foregrounding its ingredient list, clear safety standards, and production details, NerveSooth positions itself in line with that movement. For consumers already searching online about fruit-based antioxidants, plant extracts, or calming botanicals, the Nerve Sooth formula fits naturally into those ongoing conversations. The emphasis is not on prescriptive outcomes but on aligning with the curiosity that is already shaping millions of searches every month. Learn More About Nerve Soothe's Ingredients Ingredient Spotlight – What's Inside the Formula At the center of Nerve Sooth is a blend of five fruit, flower, and bark extracts paired with supporting vitamins and minerals. Each inclusion reflects ingredients people are already searching for and talking about across wellness platforms in 2025. Instead of bold promises, the spotlight remains on transparency, history, and public curiosity. Prickly PearPrickly pear has been discussed in research and wellness circles for years. This cactus fruit is frequently highlighted in conversations about antioxidants and resilience against stressors that affect the body's cells. Online discussions often link prickly pear with lifestyle practices aimed at balance and energy, which explains why searches for this ingredient continue to rise. PassionflowerPassionflower is one of the most widely referenced herbs when it comes to stress and sleep-related topics. In wellness forums and podcasts, passionflower is often brought up in connection with GABA support and calming effects. Nerve Sooth includes this extract as part of its formula in a way that reflects how consumers are already exploring its role in relaxation and rest. Marshmallow RootMarshmallow root has a long history in herbal traditions. Known for its soothing properties, this root is commonly discussed in relation to comfort and stress relief. The gelatinous texture of marshmallow root has made it a frequent point of conversation in natural wellness communities, where it is often linked to reducing tension and promoting calmness. Corydalis (Yanhusuo Plant)Corydalis, sometimes referred to as Yanhusuo, is a flowering plant historically used in Eastern traditions. In modern research settings, it has been explored for its potential to support healthy inflammation levels. This makes it a natural fit for a formula that positions itself within the broader trend of lifestyle-based approaches to comfort and balance. California PoppyThe California poppy is often associated with calming and sleep-inducing qualities. Wellness blogs and social channels frequently mention this flower when discussing relaxation or nighttime routines. Its inclusion in Nerve Sooth reflects that public interest and aligns with current consumer conversations around rest and recovery. Together, these five plant-based inclusions form the foundation of NerveSooth. Rather than presenting them as magic bullets, the product highlights them as ingredients that people are already curious about and searching for in their own time. This approach allows Nerve Sooth to position itself within existing demand rather than making unsupported promises. What Reddit, Podcasts & TikTok Creators Are Saying Nerve wellness has become a mainstream topic across digital platforms in 2025. On Reddit, thousands of posts appear in threads where users trade questions, personal routines, and supplement comparisons. While no single voice dominates the conversation, the volume of posts reveals how widespread the interest has become. Terms like 'nerve reset,' 'daily comfort routine,' and 'herbal support' now appear alongside broader discussions about stress, focus, and restorative sleep. Podcasts are also shaping the dialogue. Health and lifestyle shows often invite guests to share insights about plant-based ingredients, daily rituals, or broader wellness strategies. Listeners respond with curiosity, leaving comments that highlight a growing appetite for information that feels practical and approachable. Instead of waiting for complex scientific studies, audiences are looking for perspectives that make sense in the context of everyday life. TikTok has amplified this trend even further. Short-form creators post quick takes on supplements, natural practices, and nerve-related lifestyle hacks that spread rapidly through algorithm-driven feeds. Hashtags connected to nerve support, calming herbs, and natural remedies have gathered millions of views, showing how strongly these topics resonate with a wide audience. Nerve Sooth enters this environment at a time when public conversations are fueling awareness faster than traditional advertising ever could. Instead of claiming ownership of these discussions, the product positions itself within them. By highlighting familiar ingredients and maintaining an ingredient-first message, NerveSooth reflects what audiences are already searching for, watching, and sharing across platforms. This cultural alignment gives the product a place in conversations without overstating what it can do. As nerve support continues trending across digital communities, Nerve Sooth fits naturally into the broader narrative that people are shaping online every day. Who Might Be Drawn to This Type of Supplementation in 2025 The rise of nerve support discussions in 2025 has revealed the kinds of people most interested in exploring natural supplementation. Rather than one narrow demographic, the trend cuts across multiple communities, each with its own reasons for paying closer attention to formulas like Nerve Sooth. Biohackers and Performance SeekersIndividuals who identify as biohackers are always looking for ways to fine-tune daily routines. They follow emerging science, test new supplements, and track changes in focus, energy, and comfort. NerveSooth fits into this pattern of curiosity, offering a blend of plant-based extracts that biohackers may choose to explore as part of their personal experiments. Wellness EnthusiastsThis group includes people focused on balance, stress management, and overall lifestyle improvement. They watch wellness content, follow social media trends, and look for products aligned with transparency and natural ingredients. For them, Nerve Sooth offers a supplement that reflects the type of choices they are already exploring. Preparedness CommunitiesAnother growing audience in 2025 comes from preparedness and resilience-minded groups. These individuals look for tools and resources that could contribute to long-term self-reliance. Within these communities, plant-based supplementation has become a recurring theme. NerveSooth's design and ingredient-first framing allow it to align with those conversations. Everyday Consumers Seeking AlternativesBeyond niche groups, a wider audience of everyday consumers has begun showing interest in non-clinical wellness options. These are people who search for alternatives when traditional solutions feel limited. Their decisions are often shaped by what they read online, hear on podcasts, or see shared by peers. Nerve Sooth fits into that broader wave of exploration without making direct promises about outcomes. Together, these audiences highlight how diverse the interest in nerve support has become. From early adopters to casual shoppers, the momentum in 2025 reflects a cultural shift toward self-guided wellness. Nerve Sooth positions itself within this growing demand, meeting curiosity with transparency and ingredient clarity. Read About the Neuro Soothe Transparency Mission Emerging Wellness & Performance Innovation – 2025 Market Reflections The year 2025 is shaping up as one of the most active periods for consumer-driven wellness and performance solutions. Across the health and lifestyle industry, the emphasis has shifted away from top-down clinical authority and toward self-guided practices. Consumers want more control, more transparency, and more choice in how they approach their personal well-being. This shift is visible in search data, social media discussions, and purchasing behavior. Phrases like 'alternative support systems,' 'daily energy routines,' and 'plant-based balance' appear more frequently across digital platforms than ever before. The signal is clear: people are building their own frameworks for health and performance, often mixing supplements, lifestyle adjustments, and content from online communities. Within this environment, products like Nerve Sooth are positioned not as replacements for medical solutions, but as part of a wider category of consumer options. Shoppers who explore nerve support are often the same people comparing adaptogens, herbal teas, meditation routines, or other non-clinical approaches. The common thread is the desire for autonomy — the ability to choose from a spectrum of tools that feel practical and accessible. This evolution also reflects the early stages of adoption trends. Where once supplementation focused on broad categories like 'multivitamins' or 'energy boosters,' the market now features more specific niches, including nerve support, cognitive focus, and sleep optimization. Consumers view these niches not as medical claims, but as lifestyle categories. NerveSooth aligns with this expectation by presenting a formula built on widely discussed ingredients, clear labeling, and consumer-friendly guarantees. In many ways, 2025 is less about promises and more about positioning. The public is asking brands to show where they fit in the bigger picture of wellness and performance. Nerve Sooth reflects that by standing as a participant in the conversation, framed around curiosity, ingredient clarity, and alignment with what audiences already expect. The Public Debate Around Nerve Support – Signals, Skepticism, and Saturation As interest in nerve support grows, so does the debate. Public conversations often reflect both optimism and caution, highlighting the complexity of how consumers approach new supplements in 2025. Positive ThemesMany see the rise of nerve support as part of a broader cultural shift toward self-directed wellness. For these consumers, supplements like Nerve Sooth represent a way to explore natural approaches without relying entirely on traditional options. Online testimonials and community discussions often describe renewed confidence in making personal choices, with emphasis on transparency and ingredient familiarity. Skeptical VoicesAt the same time, a segment of the public remains cautious. Some question whether plant-based supplementation offers measurable benefits or whether rising interest is more trend-driven than evidence-based. On Reddit threads and comment sections, skeptics ask about long-term research, regulatory oversight, and the role of lifestyle factors outside supplementation. Their voices add balance to the conversation, reminding others to make informed decisions and consult qualified professionals. Neutral ObserversA growing middle group approaches the category with curiosity but no strong opinion. These individuals track trends, read articles, and listen to podcasts, but are not quick to adopt new products. For them, nerve support remains an emerging idea, interesting enough to follow but not yet part of their daily life. This mix of enthusiasm, skepticism, and watchful curiosity defines the public debate. Nerve Sooth is positioned not as a definitive solution, but as a participant in this larger discussion. By presenting itself with transparency and ingredient clarity, NerveSooth fits into an environment where consumers value honesty as much as innovation. About Nerve Sooth Nerve Sooth presents itself as more than a product. It is positioned as part of a broader conversation around wellness and transparency in 2025. The brand highlights an ingredient-first mission, focusing on clarity and education rather than exaggerated promises. The goal of NerveSooth is to reflect what consumers are asking for: supplements that are easy to understand, straightforward in their formulation, and aligned with standards people trust. The formula emphasizes plant-based extracts that are frequently discussed in wellness spaces, backed by a clear presentation of what the product contains and what it does not. This approach fits the 2025 expectation that companies act more like educators than advertisers. Rather than telling people what choices to make, Nerve Sooth provides information that allows individuals to decide for themselves. The formula's positioning around non-GMO standards, gluten-free labeling, and GMP-certified production demonstrates alignment with values that matter to consumers today. By maintaining this mission, NerveSooth stands as an example of how supplement brands can participate in public discussions without overstating their role. The emphasis remains on ingredient transparency, consumer empowerment, and alignment with the cultural shift toward self-guided wellness. Contact Nerve Sooth Email: chris@ Phone (US): 1 (888) 273-8270 Website: Final Disclaimer This press release is for informational purposes only. The information contained herein does not constitute medical advice, diagnosis, or treatment and has not been evaluated by the Food and Drug Administration (FDA). Nerve Sooth is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician or qualified healthcare provider before beginning any new supplement, routine, or health program. Some links in this release may be promotional in nature and may lead to third-party websites. The publisher or author may receive compensation through affiliate commissions if a purchase is made through these links. This compensation does not affect the price you pay and helps support continued research and content publication. Results described or implied may not be typical and should not be interpreted as guarantees. Statements made about ingredients or outcomes reflect public discussion and historical usage only, and are not endorsed by medical professionals or regulatory agencies. Always do your own research and make informed decisions. CONTACT: Email: chris@ Phone (US): 1 (888) 273-8270
Yahoo
3 hours ago
- Yahoo
Warren Buffett Bets Big on UnitedHealth, Slashes Apple Stake Again
Aug 15 - Berkshire Hathaway (NYSE:BRK.B), led by Warren Buffett (Trades, Portfolio), shook up its portfolio in Q2 2025 with a fresh $1.57 billion investment in UnitedHealth Group (NYSE:UNH), scooping up roughly 5 million shares. This marks Berkshire's first stake in the health insurer since 2010, and the move helped send UNH shares soaring more than 10% in after-hours trading. Warning! GuruFocus has detected 5 Warning Sign with UNH. At the same time, Berkshire trimmed its long-standing Apple (NASDAQ:AAPL) position by 20 million shares, cutting the stake to 280 million shares valued at about $57.4 billion. Bank of America (NYSE:BAC) was also reduced by 26 million shares, leaving 605 million shares worth roughly $28 billion. The firm fully exited T-Mobile (NASDAQ:TMUS) and scaled back holdings in Charter Communications (NASDAQ:CHTR). Berkshire didn't just sell, it added to Chevron (CVX), Lennar (LEN), Constellation Brands (STZ), and Domino's Pizza (DPZ), while opening smaller positions in Allegion (NYSE:ALLE), D.R. Horton (DHI), and Lamar Advertising (LAMR). The reshuffle leaves Berkshire's top five holdings, AAPL, American Express (NYSE:AXP), BAC, Coca-Cola (NYSE:KO), and CVX, making up about 75% of its $258 billion equity portfolio. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Why Molina Healthcare (MOH) Stock Is Up Today
What Happened? Shares of healthcare insurance company Molina Healthcare (NYSE:MOH) jumped 4.7% in the afternoon session after news that Warren Buffett's Berkshire Hathaway disclosed a new stake in competitor UnitedHealth Group, lifting the broader health insurance sector. The positive sentiment spread across the health insurance industry after a regulatory filing revealed that Warren Buffett's Berkshire Hathaway had taken a roughly $1.6 billion stake in sector leader UnitedHealth Group. This news spurred a broad rally, with Centene, Elevance Health, and CVS Health also seeing their shares climb. After the initial pop the shares cooled down to $167.27, up 4.8% from previous close. Is now the time to buy Molina Healthcare? Access our full analysis report here, it's free. What Is The Market Telling Us Molina Healthcare's shares are quite volatile and have had 18 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 2 days ago when the stock gained 3% on the news that markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth-oriented sectors like healthcare, as they reduce the cost of borrowing for research and innovation and increase the present value of future earnings. Molina Healthcare is down 41.8% since the beginning of the year, and at $167.27 per share, it is trading 53.6% below its 52-week high of $360.77 from September 2024. Investors who bought $1,000 worth of Molina Healthcare's shares 5 years ago would now be looking at an investment worth $855.36. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data